检索结果 - Heidi Roschitzki‐Voser

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Design, construction, and characterization of a second‐generation DARPin library with reduced hydrophobicity

    Design, construction, and characterization of a second‐generation DARPin library with reduced hydrophobicity 由 Markus A. Seeger, Reto Zbinden, Andreas Flütsch, Petrus G. M. Gutte, Sibylle Engeler, Heidi Roschitzki‐Voser, Markus G. Grütter

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism

    Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism 由 Andreas Schweizer, Heidi Roschitzki‐Voser, Patrick Amstutz, Christophe Briand, Maya Gulotti-Georgieva, Eva Prenosil, Hans Binz, Guido Capitani, Antonio Baici, Andreas Plückthun, Markus G. Grütter

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

    Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP) 由 Rafał Dziadziuszko, Egbert F. Smit, Urania Dafni, Juergen Wolf, Bartosz Wasąg, Wojciech Biernat, Stephen P. Finn, Roswitha Kammler, Zoi Tsourti, Manuela Rabaglio, Barbara Ruepp, Heidi Roschitzki‐Voser, Rolf A. Stahel, Enriqueta Felip, Solange Peters

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)

    Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic... 由 Solange Peters, Enriqueta Felip, Urania Dafni, Amanda Tufman, Matthias Gückenberger, Ruth Álvarez, Ernest Nadal, Annemarie Becker‐Commissaris, Hansjörg Vees, Miklos Pless, Alex Martínez‐Martí, Maarten Lambrecht, Nicolaus Andratschke, Zoi Tsourti, Anne‐Christine Piguet, Heidi Roschitzki‐Voser, A. Gasca-Ruchti, Johan Vansteenkiste, Rolf A. Stahel, Dirk De Ruysscher

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

    A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from t... 由 Sanjay Popat, Alessandra Curioni‐Fontecedro, Varvara Polydoropoulou, Riyaz Shah, Mary O’Brien, A. Pope, P.M. Fisher, James Spicer, A. Roy, D. Gilligan, Oliver Gautschi, Ernest Nadal, Wolf-Dieter Janthur, Rafael López Castro, Rosario García Campelo, Heidi Roschitzki‐Voser, Barbara Ruepp, Sylvie Rusakiewicz, Solange Peters, Rolf A. Stahel

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

    A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Onc... 由 Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni, R. Shah, Mary O’Brien, A. Pope, P.M. Fisher, James Spicer, A. Roy, D. Gilligan, Oliver Gautschi, Ernest Nadal, Wolf-Dieter Janthur, Rafael López Castro, Rosario García Campelo, Sylvie Rusakiewicz, Igor Letovanec, Varvara Polydoropoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, A. Gasca-Ruchti, Solange Peters, Rolf A. Stahel

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

    A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutat... 由 Ross A. Soo, Ji‐Youn Han, Urania Dafni, Byoung Chul Cho, Chong Ming Yeo, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Linda Coate, Mariano Provencio, Rosario García Campelo, Sinéad Cuffe, Sayed M.S. Hashemi, Martin Früh, Bartomeu Massutí, José García-Sánchez, Manuel Dómine, Margarita Majem, J.M. Sánchez-Torres, Christian Britschgi, Miklos Pless, Georgia Dimopoulou, Heidi Roschitzki‐Voser, Barbara Ruepp, Rafael Rosell, Rolf A. Stahel, Solange Peters, Rolf A. Stahel, Solange Peters, Ross A. Soo, Ji‐Youn Han, Martin Früh, Mariano Provencio, Linda Coate, Urania Dafni, Anita Hiltbrunner, Barbara Ruepp, Heidi Roschitzki‐Voser, Anita Hiltbrunner, Adriana Gasca-Ruchti, Nino Giacomelli, Rosita Kammler, Nesa Marti, Lionel Nobs, Mariana Pardo-Contreras, Rita Pfister, Anne‐Christine Piguet, Sabrina Ribeli-Hofmann, Virginia Rodriguez Martinez, Heidi Roschitzki‐Voser, Susanne Roux, Barbara Ruepp, Magdalena Sánchez-Hohl, Mirjam Schneider, Robin Schweri, Sandra Troesch, Isabel Zigomo, Urania Dafni, Zoi Tsourti, Panagiota Zygoura, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, María Teresa Sariñena Fernandez, Eva Pereira, Carolina Simona, Lisa Tucker, Jillian Burnes, Aisling Barrett, Meghan McGrillen, Catherine Berset, Christine Biaggi, M. Reist, Priska Rentsch, Linda Coate, Sinéad Cuffe, Sayed M.S. Hashemi, Ernest Nadal, Enric Carcereny, Javier de Castro, María Ángeles Sala, Reyes Bernabé, Mariano Provencio, Rosario García Campelo, Bartomeu Massutí, José López García, Manuel Dómine, Margarita Majem, José Miguel Sánchez, Martin Früh, Christian Britschgi, Miklos Pless, Solange Peters, Ross A. Soo, Chong Ming Yeo, Ji‐Youn Han, Byoung Chul Cho

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

    A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and... 由 Solange Peters, Sarah Danson, Baktiar Hasan, Urania Dafni, Niels Reinmuth, Margarita Majem, Kurt G. Tournoy, Michael Mark, Miklos Pless, Manuel Cobo, Delvys Rodríguez‐Abreu, L. Falchero, Teresa Morán, A.L. Ortega Granados, I. Monnet, Katja Mohorčič, B. Massuti Sureda, Daniel Betticher, Ingel Demedts, José Macías, Sinéad Cuffe, Andrea Luciani, José García Sánchez, Alessandra Curioni‐Fontecedro, Oliver Gautschi, Gillian Price, Linda Coate, Roger von Moos, Christoph Zielinski, Mariano Provencio, Jessica Menis, Barbara Ruepp, Alessia Pochesci, Heidi Roschitzki‐Voser, Benjamin Besse, Manuela Rabaglio, Mary O’Brien, Rolf A. Stahel

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 S... 由 Solange Peters, Jean-Louis Pujol, Urania Dafni, Manuel Dómine, Sanjay Popat, Martin Reck, J. Andrade, Annemarie Becker‐Commissaris, Denis Moro‐Sibilot, Alessandra Curioni‐Fontecedro, Olivier Molinier, Kristiaan Nackaerts, A. Insa Mollá, R. Gervais, Guillermo López-Vivanco, J. Madelaine, Julien Mazières, Martin Faehling, Frank Griesinger, Margarita Majem, J.L. González-Larriba, Mariano Provencio, Katerina Vervita, Heidi Roschitzki‐Voser, Barbara Ruepp, Paul Mitchell, Rolf A. Stahel, C. Le Péchoux, Dirk De Ruysscher, Rolf A. Stahel, Anita Hiltbrunner, Mariana Pardo-Contreras, A. Gasca-Ruchti, Nino Giacomelli, Roswitha Kammler, Nesa Marti, Rita Pfister, Anne‐Christine Piguet, Susanne Roux, Sandra Troesch, M. Schneider, Robin Schweri, Isabel Zigomo, Zoi Tsourti, Panagiota Zygoura, S. Tsouprou, Marie Kassapian, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Franck Morin, Elodie Amour, G. Mariaule, N. Archirel, María Dolores Arnaiz Fernández, E. Pereira, Llúcia Benito, K. Lopez, Ainhoa Hernández, Sarah Chinchen, H. Jurkovic, Alan S. Livingstone, Jerry W. Mitchell, Macie B. Walker, Paul Mitchell, S. Ng, Christopher Steer, Karen Briscoe, Amina Saqib, Ehtesham Abdi, Baerin Houghton, Kenneth J. O’Byrne, B.R. Chittajallu, Brett Hughes, A. Black, Kristiaan Nackaerts, Henrica M.J. Werner, R. Gervais, Gérard Zalcman, F. Vaylet, P. Merle, I. Monnet, Denis Moro‐Sibilot, Olivier Molinier, Nicolas Girard, P.-J. Souquet, Fabrice Barlési, D. Debieuvre, Hélène Senellart, M. Poudenx, A. Dixmier, Damien Pouessel, Jacques Cadranel, H. Léna, Élisabeth Quoix, S. Friard, Clarisse Audigier-Valette, Julien Mazières, Éric Pichon, Martin Faehling

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: